Timbuktu Capital Management’s Pfizer PFE Stock Holding History

Timbuktu Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.5K	Buy	+1,184	New	+$31K	0.04%	127

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Timbuktu Capital Management's PFE Position: Q2 2026 in Review

Timbuktu Capital Management opened a new position in Pfizer (PFE) in Q2 2026: 1,184 shares worth $28.5K. The stake represents 0.04% of the portfolio and ranks #127 among its holdings.

2,813 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Timbuktu Capital Management held 1,184 shares of Pfizer worth $28.5K as of Q2 2026.
Pfizer was a new Timbuktu Capital Management position in Q2 2026.
Pfizer made up 0.04% of Timbuktu Capital Management's portfolio in Q2 2026, its #127 holding.
2,813 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Timbuktu Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.